Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Early Metabolic Response as a Predictor of Treatment Outcome in Patients With Metastatic Soft Tissue Sarcomas

MYRELLA VLENTERIE, WIM JG OYEN, NEELTJE STEEGHS, INGRID M.E. DESAR, REMY B. VERHEIJEN, ANNE MIEK KOENEN, WILLEM GROOTJANS, LIOE-FEE DE GEUS-OEI, NIELKA P. VAN ERP and WINETTE TA VAN DER GRAAF
Anticancer Research March 2019, 39 (3) 1309-1316; DOI: https://doi.org/10.21873/anticanres.13243
MYRELLA VLENTERIE
1Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: myrella.vlenterie{at}radboudumc.nl
WIM JG OYEN
2Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NEELTJE STEEGHS
3Department of Medical Oncology, Antoni van Leeuwenhoek – Netherlands Cancer Institute, Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
INGRID M.E. DESAR
1Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
REMY B. VERHEIJEN
4Department of Pharmacy, Antoni van Leeuwenhoek – Netherlands Cancer Institute, Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANNE MIEK KOENEN
3Department of Medical Oncology, Antoni van Leeuwenhoek – Netherlands Cancer Institute, Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WILLEM GROOTJANS
5Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LIOE-FEE DE GEUS-OEI
2Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands
5Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NIELKA P. VAN ERP
6Department of Pharmacy, Radboud University Medical Center, Nijmegen, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WINETTE TA VAN DER GRAAF
1Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands
3Department of Medical Oncology, Antoni van Leeuwenhoek – Netherlands Cancer Institute, Amsterdam, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 39 no. 3 1309-1316
DOI 
https://doi.org/10.21873/anticanres.13243
PubMed 
30842163

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received January 6, 2019
  • Revision received January 19, 2019
  • Accepted January 22, 2019
  • Published online March 6, 2019.

Copyright & Usage 
Copyright© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. MYRELLA VLENTERIE1⇑,
  2. WIM JG OYEN2,
  3. NEELTJE STEEGHS3,
  4. INGRID M.E. DESAR1,
  5. REMY B. VERHEIJEN4,
  6. ANNE MIEK KOENEN3,
  7. WILLEM GROOTJANS5,
  8. LIOE-FEE DE GEUS-OEI2,5,
  9. NIELKA P. VAN ERP6,* and
  10. WINETTE TA VAN DER GRAAF1,3,*
  1. 1Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands
  2. 2Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, the Netherlands
  3. 3Department of Medical Oncology, Antoni van Leeuwenhoek – Netherlands Cancer Institute, Amsterdam, the Netherlands
  4. 4Department of Pharmacy, Antoni van Leeuwenhoek – Netherlands Cancer Institute, Amsterdam, the Netherlands
  5. 5Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands
  6. 6Department of Pharmacy, Radboud University Medical Center, Nijmegen, the Netherlands
  1. Correspondence to: Myrella Vlenterie, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, the Netherlands. Tel: +31 243610353, e-mail: myrella.vlenterie{at}radboudumc.nl
View Full Text

Statistics from Altmetric.com

Cited By...

  • 8 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 39, Issue 3
March 2019
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Early Metabolic Response as a Predictor of Treatment Outcome in Patients With Metastatic Soft Tissue Sarcomas
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
16 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Early Metabolic Response as a Predictor of Treatment Outcome in Patients With Metastatic Soft Tissue Sarcomas
MYRELLA VLENTERIE, WIM JG OYEN, NEELTJE STEEGHS, INGRID M.E. DESAR, REMY B. VERHEIJEN, ANNE MIEK KOENEN, WILLEM GROOTJANS, LIOE-FEE DE GEUS-OEI, NIELKA P. VAN ERP, WINETTE TA VAN DER GRAAF
Anticancer Research Mar 2019, 39 (3) 1309-1316; DOI: 10.21873/anticanres.13243

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Early Metabolic Response as a Predictor of Treatment Outcome in Patients With Metastatic Soft Tissue Sarcomas
MYRELLA VLENTERIE, WIM JG OYEN, NEELTJE STEEGHS, INGRID M.E. DESAR, REMY B. VERHEIJEN, ANNE MIEK KOENEN, WILLEM GROOTJANS, LIOE-FEE DE GEUS-OEI, NIELKA P. VAN ERP, WINETTE TA VAN DER GRAAF
Anticancer Research Mar 2019, 39 (3) 1309-1316; DOI: 10.21873/anticanres.13243
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Efficacy of Platinum-based Chemotherapy for Platinum-sensitive Recurrent Ovarian Cancer During PARP Inhibitor Treatment: A Multicenter Retrospective Study
  • Uniformity Between Serological Biomarker Test, Esophago-gastro-duodenoscopy and Biopsy Histology in Triage of Upper Abdominal Symptoms in Gastroscopy Referral Patients
  • Renal Function With Enfortumab Vedotin in Metastatic Urothelial Carcinoma: A Multicenter Retrospective Study in Japan
Show more Clinical Studies

Similar Articles

Keywords

  • Sarcoma
  • Soft tissue
  • positron-emission tomography
  • pharmacokinetics
  • Pazopanib
  • pharmacodynamics
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire